University of California Davis Health Urology

Topics

• Prostate Cancer Diagnosis and Treatment 233
• Bladder and Urothelial Cancer Treatments 206
• Renal cell carcinoma treatment 81
• Kidney Stones and Urolithiasis Treatments 64
• Urological Disorders and Treatments 63
• Prostate Cancer Treatment and Research 54
• Testicular diseases and treatments 45
• Pediatric Urology and Nephrology Studies 39
• Urinary Bladder and Prostate Research 32
• Lung Cancer Treatments and Mutations 31
• Pelvic floor disorders treatments 31
• Tissue Engineering and Regenerative Medicine 30

Most cited

1. Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report.

   Chest · 2021 · 806 citations · Susan Murin

2. Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 415 citations · Tianhong Li

3. Executive Summary: Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report.

   Chest · 2021 · 351 citations · Susan Murin

4. Antithrombotic Therapy for VTE Disease: Compendium and Review of CHEST Guidelines 2012-2021.

   Chest · 2024 · 106 citations · Susan Murin

5. Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.

   The Lancet. Oncology · 2021 · 402 citations · Erik Busby, Kirk Keegan

6. Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial.

   JAMA oncology · 2021 · 311 citations ·